| Product Name | MF | CAS | Details |
|---|
| Antimalarial agent 26 | C20H22N4O3 | 2299199-56-5 | Details |
| ATR-IN-23 | C20H22N6O3S2 | 2923800-62-6 | Details |
| TRK-IN-23 | C20H17FN4O2 | 2924344-29-4 | Details |
| Antileishmanial agent-16 | C27H37N5O4 | 2934738-41-5 | Details |
| Antileishmanial agent-17 | C27H37N5O5 | 2934738-40-4 | Details |
| Antileishmanial agent-15 | C28H39N5O4 | 2934738-38-0 | Details |
| SLMP53-2 | C26H22N2O2 | 1826116-38-4 | Details |
| Antibacterial agent 141 | C23H27ClN2O3 | 2930013-56-0 | Details |
| HDAC ligand-1 | C7H8N2O | 34840-28-3 | Details |
| HIV-1 inhibitor-56 | C22H14ClN7O2S | 2952530-45-7 | Details |
| AMPA receptor modulator-4 | C11H12ClFN2O2S | 2917551-59-6 | Details |
| Lp-PLA2-IN-12 | 2637485-14-2 | Details |
| MDM2/XIAP-IN-2 | C29H32N2O4S | 2761969-85-9 | Details |
| PB131 | C16H16FN3O2 | 2924425-63-6 | Details |
| Enpp-1-IN-17 | C18H24N4O2 | 2289736-54-3 | Details |
| Mcl-1 inhibitor 13 | 2445466-06-6 | Details |
| MEK-IN-6 hydrate | 2845153-35-5 | Details |
| RIP1 kinase inhibitor 5 | C13H17F2NO2 | 2428422-17-5 | Details |
| Tegeprotafib | C13H11FN2O5S | 2407610-46-0 | Details |
| RIP1 kinase inhibitor 4 | 2919836-00-1 | Details |
| PCSK9-IN-17 | C16H19N5OS | 2455424-72-1 | Details |
| PCSK9-IN-16 | C16H20N6O2S3 | 2455424-51-6 | Details |
| ATR-IN-24 | C23H26N6O2 | 2370889-43-1 | Details |
| RIP1 kinase inhibitor 7 | C20H20FN3O | 2428401-23-2 | Details |
| ALK2-IN-5 | C24H32N8O2 | 2414149-20-3 | Details |
| Tau protein aggregation-IN-1 | C17H11BrN2O2 | 916179-45-8 | Details |
| RIP1 kinase inhibitor 6 | C19H18F2N2O3 | 2428401-62-9 | Details |
| TNF-α-IN-10 | C17H14O4 | 2247720-56-3 | Details |
| MEK-IN-6 | C18H20FN3O4S | 2845151-86-0 | Details |
| A1/A3 AR antagonist 3 | C22H19N5O3 | 2665804-57-7 | Details |
| Lp-PLA2-IN-15 | C22H17F5N4O3 | 1865796-11-7 | Details |
| SB-649701 | C27H28N4O3 | 935262-95-6 | Details |
| SORT-PGRN interaction inhibitor 3 | C15H19Cl2NO3 | 2691846-87-2 | Details |
| Bromodomain inhibitor-12 (edisylate) | C28H38N4O5.C2H6O6S2 | 2010124-27-1 | Details |
| Lp-PLA2-IN-14 | 2756855-66-8 | Details |
| SOS1/KRAS-IN-1 | C24H26F3N5O | 2836330-34-6 | Details |
| Bivamelagon hydrochloride | C35H54Cl2N4O4 | 2641595-55-1 | Details |
| VMAT2-IN-2 tosylate | C27H36F3NO6S | 2608770-12-1 | Details |
| IRE1α kinase-IN-9 | C24H24N2O6 | 1338933-30-4 | Details |
| SHP2-IN-14 | C22H20Cl2N8O | 2673400-91-2 | Details |
| TLR8 agonist 6 | C19H29N7O2 | 2616605-55-9 | Details |
| Lp-PLA2-IN-16 | C22H17F5N4O3 | 1865780-73-9 | Details |
| IPG7236 | C23H31N3O3S | 2756350-91-9 | Details |
| TLR7/8 agonist 8 | C24H30N6O | 2649170-16-9 | Details |
| KAT modulator-1 | C20H36O2 | 1314006-43-3 | Details |
| Bivamelagon | C35H53ClN4O4 | 2641595-54-0 | Details |
| ROCK-IN-6 | C19H19N5O8S | 2489328-74-5 | Details |
| THRβ receptor agonist-1 | 2403721-00-4 | Details |
| P2X3 antagonist 38 | C22H25F3N6O3 | 2545974-71-6 | Details |
| PI3Kγ inhibitor 7 | C31H25N9O2 | 2575863-25-9 | Details |
| CXCR4-IN-1 | C23H32N6 | 2304750-48-7 | Details |
| RET-IN-23 | C28H28FN11 | 2479961-46-9 | Details |
| TLR7/8 agonist 9 | C20H26N6O | 2649170-17-0 | Details |
| Mosnodenvir | C26H22ClF3N2O6S | 2890688-86-3 | Details |
| DGKζ-IN-1 | C27H25F3N6O2S | 2660218-70-0 | Details |
| Bromodomain inhibitor-12 | 2010124-06-6 | Details |
| Lp-PLA2-IN-13 | C22H17F5N4O4 | 2756855-62-4 | Details |
| JAK-IN-28 | C20H18ClN7O | 2445500-22-9 | Details |
| HPK1 antagonist-1 | C28H29FN6O2 | 2628489-56-3 | Details |
| Protein kinase inhibitor 5 | C29H31F2N7O | 2278204-94-5 | Details |
| IRE1α kinase-IN-8 | 1338933-29-1 | Details |
| Antifungal agent 59 | 2422019-96-1 | Details |
| STAT6-IN-3 | C32H35IN3O7P | 371919-80-1 | Details |
| SUCNR1-IN-1 | C26H22ClF3N2O4 | 2711753-52-3 | Details |
| FKBP51F67V-selective antagonist Ligand2 | C43H56N2O10 | 1680228-76-5 | Details |
| DSO-5a | C23H24N2O7 | 2195411-63-1 | Details |
| FD2056 | C23H17ClN6O2S | 2685870-87-3 | Details |
| BDM91514 | 2892824-90-5 | Details |
| SARS-CoV-2-IN-57 | C23H37N3O | 1265624-68-7 | Details |
| UPCDC30766 | C30H32F2N6O3S | 2152623-68-0 | Details |
| MmpL3-IN-2 | C27H30N2 | 2944458-65-3 | Details |
| URAT1&XO inhibitor 2 | C14H12BrNO3 | 1239488-96-0 | Details |
| BBDDL2059 | C27H36N4O4S | 2691174-27-1 | Details |
| JAK-IN-30 | C19H26N8S | 2891469-99-9 | Details |
| Antitubercular agent-39 | C26H30N4O2 | 1357796-08-7 | Details |
| Z1078601926 | C14H19FN2O | 1493256-85-1 | Details |
| DRI-C21041 | C30H21N3O7S | 2101765-78-8 | Details |
| Antiproliferative agent-32 | C19H15NO2 | 2925814-05-5 | Details |
| PROTAC α-synuclein degrader 5 | C39H41N7O10 | 2781922-42-5 | Details |
| K-80001 | C20H17FO2 | 242800-40-4 | Details |
| AMPK activator 11 | C25H20N4O2 | 2948304-00-3 | Details |
| Anticancer agent 147 | C32H40BrN3O2 | 2241283-11-2 | Details |
| FGFR-IN-11 | C28H29ClN4O4 | 2658488-68-5 | Details |
| Antiproliferative agent-30 | C24H26N4O4 | 2713553-88-7 | Details |
| CDK7-IN-22 | C22H25F3N6 | 2173190-60-6 | Details |
| PIKfyve-IN-2 | C22H22N8O | 2245319-25-7 | Details |
| PHD2-IN-1 | C21H23ClN4O5 | 2768219-28-7 | Details |
| SSI-4 | C19H21ClN4O3 | 1875084-68-6 | Details |
| URAT1&XO inhibitor 1 | C20H13N5O3S | 2669726-78-5 | Details |
| SOS1-IN-16 | C30H31F3N4O3 | 2930763-85-0 | Details |
| ETAP | C18H17N3O | 2575731-47-2 | Details |
| Antiproliferative agent-34 | C27H27N7O5 | 2910858-34-1 | Details |
| S-Gem | C13H15F2N3O6S2 | 2169925-98-6 | Details |
| DRI-C25441 | C31H21N3O6 | 2101765-83-5 | Details |
| Tubulin polymerization-IN-42 | C22H21NO5 | 2640220-51-3 | Details |
| BChE-IN-17 | C23H23BrN2O4S2 | 2425632-57-9 | Details |
| Antitumor agent-101 | C26H38N6O3 | 2848632-52-8 | Details |
| PAD4-IN-2 | C20H23BClN7O6 | 2642327-52-2 | Details |
| MAT2A-IN-12 | C20H17NO3 | 631897-75-1 | Details |
| IRAK4-IN-28 | C27H31N9O3 | 2952532-92-0 | Details |
| Product Total： Product Page： | ||||
| 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 | ||||